MedPath

Modified Extension Study to the SUmiT Trial: Evaluation of Long Term Therapy With Percutaneous Tibial Nerve Stimulation (PTNS) for Overactive Bladder Symptoms

Phase 4
Completed
Conditions
Urinary Bladder, Overactive
Interventions
Device: Urgent PC
Registration Number
NCT00928395
Lead Sponsor
Uroplasty, Inc
Brief Summary

This is a modified extension study to the SUmiT protocol UPC082008 (NCT00534521) to observe and evaluate long term therapy with PTNS on overactive bladder symptoms. Subjects must have completed the 12 weekly treatments of the original protocol, the 13 week follow up assessment, be randomized to the PTNS arm, and be considered a positive responder with moderate or marked improvement in the SUmiT Trial to be enrolled in this study. All consenting responders will continue with active PTNS therapy at an initially prescribed protocol for approximately 3 months followed by individualized symptom-based frequency of visits as determined by the subject along with their treating clinician, for up to a total of 33 months post initial 12-week therapy for a total of 3 years.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
50
Inclusion Criteria
  • Subjects who signed the informed consent and were eligible to participate in the original SUmiT Trial
  • Subjects who were randomized and treated with the active PTNS therapy during their participation in the original SUmiT Trial
  • Subject must be a positive responder from initial 12 weekly treatments as prescribed in original SUmiT Trial - 13 week GRA questionnaire must indicate "moderately" or "markedly improved" on question #1 of GRA
  • Subjects must not have started any antimuscarinics treatment since completion of original SUmiT Trial
  • Subjects must not have started any urologic Botox treatment since completion of original SUmiT Trial
  • Subjects must remain off all antimuscarinics throughout participation in trial
  • Subjects must initiate PTNS maintenance therapy within 2 weeks of their last PTNS treatment as part of SUmiT protocol UPC082008
  • Capable of giving informed consent
  • Capable and willing to follow all study-related procedures for up to 33 months for a total participation of 3 years
Exclusion Criteria
  • Pregnant as confirmed by urine pregnancy test, or plans to become pregnant during the study period
  • Subjects who were not able or willing to follow original SUmiT Trial study schedule

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Urgent PCUrgent PCThe Urgent PC Neuromodulation System is a minimally invasive neuromodulation system designed to deliver retrograde access to the sacral nerve through percutaneous electrical stimulation of the tibial nerve. The method of treatment is referred to as Percutaneous Tibial Nerve Stimulation (PTNS).
Primary Outcome Measures
NameTimeMethod
Proportion of Patients Reporting "Moderately" or "Markedly" Improved on the Global Response Assessment (GRA) at 36 Months as Compared to Baseline36 months total

The GRA asked patients, "Compared to the last time you completed this questionnaire, how would you rate your bladder symptoms now?" and was a 7-level Assessment (markedly improved, moderately improved, slightly improved, no change, slightly worse, moderately worse, markedly worse).

Secondary Outcome Measures
NameTimeMethod
GRA Subset of Individual Bladder Symptom Components to Include Urgency, Frequency and Urge Incontinence.every three months for 36 months
Change in Voiding Diary Parameters.every three months for 36 months
Change in OAB-q and SF-36 Questionnaires.every three months for 36 months

Trial Locations

Locations (12)

Alliance Urology Specialists

🇺🇸

Greensboro, North Carolina, United States

Gregory L. Davis, M.D., FACOG, Inc.

🇺🇸

Chico, California, United States

Greenwich Urological Associates, P.C.

🇺🇸

Greenwich, Connecticut, United States

Grand Rapids Women's Health DBA Female Pelvic Medicine & Urogynecology Institue of Michigan

🇺🇸

Grand Rapids, Michigan, United States

Mercy Health Partners at the Lakes

🇺🇸

Muskegon, Michigan, United States

Beaumont Hospital

🇺🇸

Royal Oak, Michigan, United States

Capital Region Urological Surgeons, PLLC

🇺🇸

Albany, New York, United States

Urology Health Center, PC

🇺🇸

Fremont, Nebraska, United States

Central Missouri Women's Healthcare, LLC

🇺🇸

White Plains, New York, United States

Virginia Urology

🇺🇸

Richmond, Virginia, United States

Athena Urology

🇺🇸

Issaquah, Washington, United States

Specialists in Urology

🇺🇸

Naples, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath